| Product NDC: | 67877-294 | 
| Proprietary Name: | ibuprofen | 
| Non Proprietary Name: | ibuprofen | 
| Active Ingredient(s): | 400 mg/1 & nbsp; ibuprofen | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 67877-294 | 
| Labeler Name: | Ascend Laboratories, LLC | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA090796 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20120222 | 
| Package NDC: | 67877-294-01 | 
| Package Description: | 100 TABLET in 1 BOTTLE (67877-294-01) | 
| NDC Code | 67877-294-01 | 
| Proprietary Name | ibuprofen | 
| Package Description | 100 TABLET in 1 BOTTLE (67877-294-01) | 
| Product NDC | 67877-294 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | ibuprofen | 
| Dosage Form Name | TABLET | 
| Route Name | ORAL | 
| Start Marketing Date | 20120222 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Ascend Laboratories, LLC | 
| Substance Name | IBUPROFEN | 
| Strength Number | 400 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |